These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

636 related items for PubMed ID: 17963460

  • 41. Successful treatment of multidrug resistant Acinetobacter baumannii meningitis.
    Saçar S, Turgut H, Cenger DH, Coşkun E, Asan A, Kaleli I.
    J Infect Dev Ctries; 2007 Dec 01; 1(3):342-4. PubMed ID: 19734617
    [Abstract] [Full Text] [Related]

  • 42. Colistin, meropenem and rifampin in a combination therapy for multi-drug-resistant Acinetobacter baumannii multifocal infection. A case report.
    Biancofiore G, Tascini C, Bisà M, Gemignani G, Bindi ML, Leonildi A, Giannotti G, Menichetti F.
    Minerva Anestesiol; 2007 Mar 01; 73(3):181-5. PubMed ID: 17159765
    [Abstract] [Full Text] [Related]

  • 43. Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia.
    Betrosian AP, Frantzeskaki F, Xanthaki A, Douzinas EE.
    J Infect; 2008 Jun 01; 56(6):432-6. PubMed ID: 18501431
    [Abstract] [Full Text] [Related]

  • 44. Postantibiotic effects of tigecycline, colistin sulfate, and levofloxacin alone or tigecycline-colistin sulfate and tigecycline-levofloxacin combinations against Acinetobacter baumannii.
    Ozbek B, Sentürk A.
    Chemotherapy; 2010 Jun 01; 56(6):466-71. PubMed ID: 21088399
    [Abstract] [Full Text] [Related]

  • 45. A retrospective analysis of carbapenem-resistant Acinetobacter baumannii-mediated nosocomial pneumonia and the in vitro therapeutic benefit of cefoperazone/sulbactam.
    Xia J, Zhang D, Xu Y, Gong M, Zhou Y, Fang X.
    Int J Infect Dis; 2014 Jun 01; 23():90-3. PubMed ID: 24726664
    [Abstract] [Full Text] [Related]

  • 46. High mortality rates among solid organ transplant recipients infected with extensively drug-resistant Acinetobacter baumannii: using in vitro antibiotic combination testing to identify the combination of a carbapenem and colistin as an effective treatment regimen.
    Shields RK, Kwak EJ, Potoski BA, Doi Y, Adams-Haduch JM, Silviera FP, Toyoda Y, Pilewski JM, Crespo M, Pasculle AW, Clancy CJ, Nguyen MH.
    Diagn Microbiol Infect Dis; 2011 Jun 01; 70(2):246-52. PubMed ID: 21353436
    [Abstract] [Full Text] [Related]

  • 47. Comparison of Tigecycline or Cefoperazone/Sulbactam therapy for bloodstream infection due to Carbapenem-resistant Acinetobacter baumannii.
    Niu T, Luo Q, Li Y, Zhou Y, Yu W, Xiao Y.
    Antimicrob Resist Infect Control; 2019 Jun 01; 8():52. PubMed ID: 30886705
    [Abstract] [Full Text] [Related]

  • 48. Antimicrobial effects of varied combinations of meropenem, sulbactam, and colistin on a multidrug-resistant Acinetobacter baumannii isolate that caused meningitis and bacteremia.
    Lee CH, Tang YF, Su LH, Chien CC, Liu JW.
    Microb Drug Resist; 2008 Sep 01; 14(3):233-7. PubMed ID: 18707240
    [Abstract] [Full Text] [Related]

  • 49. In vitro activities of rifampin, colistin, sulbactam and tigecycline tested alone and in combination against extensively drug-resistant Acinetobacter baumannii.
    Dong X, Chen F, Zhang Y, Liu H, Liu Y, Ma L.
    J Antibiot (Tokyo); 2014 Sep 01; 67(9):677-80. PubMed ID: 25095805
    [Abstract] [Full Text] [Related]

  • 50. Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections.
    Bassetti M, Repetto E, Righi E, Boni S, Diverio M, Molinari MP, Mussap M, Artioli S, Ansaldi F, Durando P, Orengo G, Bobbio Pallavicini F, Viscoli C.
    J Antimicrob Chemother; 2008 Feb 01; 61(2):417-20. PubMed ID: 18174197
    [Abstract] [Full Text] [Related]

  • 51. Synergic in-vitro activity of imipenem and sulbactam against Acinetobacter baumannii.
    Choi JY, Park YS, Cho CH, Park YS, Shin SY, Song YG, Yong D, Lee K, Kim JM.
    Clin Microbiol Infect; 2004 Dec 01; 10(12):1098-101. PubMed ID: 15606639
    [Abstract] [Full Text] [Related]

  • 52. Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
    Jamal W, Salama M, Dehrab N, Al Hashem G, Shahin M, Rotimi VO.
    J Hosp Infect; 2009 Jul 01; 72(3):234-42. PubMed ID: 19493588
    [Abstract] [Full Text] [Related]

  • 53. Susceptibility of the Acinetobacter calcoaceticus-A. baumannii complex to imipenem, meropenem, sulbactam and colistin.
    Dueñas Díez AI, Bratos Pérez MA, Eiros Bouza JM, Almaraz Gómez A, Gutiérrez Rodríguez P, Miguel Gómez MA, Orduña Domingo A, Rodríguez-Torres A.
    Int J Antimicrob Agents; 2004 May 01; 23(5):487-93. PubMed ID: 15120728
    [Abstract] [Full Text] [Related]

  • 54. Colistin and tigecycline susceptibility among multidrug-resistant Acinetobacter baumannii isolated from ventilator-associated pneumonia.
    Dizbay M, Altuncekic A, Sezer BE, Ozdemir K, Arman D.
    Int J Antimicrob Agents; 2008 Jul 01; 32(1):29-32. PubMed ID: 18539006
    [Abstract] [Full Text] [Related]

  • 55. Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity.
    Lenhard JR, Thamlikitkul V, Silveira FP, Garonzik SM, Tao X, Forrest A, Soo Shin B, Kaye KS, Bulitta JB, Nation RL, Li J, Tsuji BT.
    J Antimicrob Chemother; 2017 May 01; 72(5):1415-1420. PubMed ID: 28333347
    [Abstract] [Full Text] [Related]

  • 56. Multidrug-resistant Acinetobacter baumannii bacteraemia: clinical features, antimicrobial therapy and outcome.
    Kuo LC, Lai CC, Liao CH, Hsu CK, Chang YL, Chang CY, Hsueh PR.
    Clin Microbiol Infect; 2007 Feb 01; 13(2):196-198. PubMed ID: 17328733
    [Abstract] [Full Text] [Related]

  • 57. Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains.
    Li J, Nation RL, Owen RJ, Wong S, Spelman D, Franklin C.
    Clin Infect Dis; 2007 Sep 01; 45(5):594-8. PubMed ID: 17682994
    [Abstract] [Full Text] [Related]

  • 58. In vitro activity of tigecycline in combination with cefoperazone-sulbactam against multidrug-resistant Acinetobacter baumannii.
    Liu B, Bai Y, Liu Y, Di X, Zhang X, Wang R, Wang J.
    J Chemother; 2015 Oct 01; 27(5):271-6. PubMed ID: 25068186
    [Abstract] [Full Text] [Related]

  • 59. Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments.
    Rodríguez Guardado A, Blanco A, Asensi V, Pérez F, Rial JC, Pintado V, Bustillo E, Lantero M, Tenza E, Alvarez M, Maradona JA, Cartón JA.
    J Antimicrob Chemother; 2008 Apr 01; 61(4):908-13. PubMed ID: 18281693
    [Abstract] [Full Text] [Related]

  • 60. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.
    Koomanachai P, Tiengrim S, Kiratisin P, Thamlikitkul V.
    Int J Infect Dis; 2007 Sep 01; 11(5):402-6. PubMed ID: 17291803
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.